{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:57:22Z","timestamp":1794023842064,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.vaccine.2023.11.034","type":"journal-article","created":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T15:25:32Z","timestamp":1700925932000},"page":"7671-7681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system"],"prefix":"10.1016","volume":"41","author":[{"given":"Stavroula","family":"Piliou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo A.","family":"Farman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7382-9766","authenticated-orcid":false,"given":"Shathviga","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Mastroeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.11.034_b0005","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1073\/pnas.93.20.11109","article-title":"Analysis of the genetic differences between Neisseria meningitidis and Neisseria gonorrhoeae: Two closely related bacteria expressing two different pathogenicities","volume":"93","author":"Tinsley","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2023.11.034_b0010","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","article-title":"Meningococcal disease: Clinical presentation and sequelae","volume":"30","author":"Pace","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.034_b0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1071\/SH19061","article-title":"Epidemiology of gonorrhoea: A global perspective","volume":"16","author":"Kirkcaldy","year":"2019","journal-title":"Sex Health"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0020","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/651505","article-title":"Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine Era - United States, 2000\u20132005","volume":"201","author":"Harrison","year":"2010","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.034_b0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"issue":"8346","key":"10.1016\/j.vaccine.2023.11.034_b0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic Similarities Between Brain Components and Bacteria Causing Meningitis: Implications for Vaccine Development and Pathogenesis","volume":"322","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.034_b0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40265-018-0869-7","article-title":"MenB-FHbp Meningococcal Group B Vaccine (Trumenba\u00ae): A Review in Active Immunization in Individuals Aged \u2265 10 Years","volume":"78","author":"Shirley","year":"2018","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.034_b0040","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: A multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.034_b0045","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of Complement Factor H (fH) to Neisseria meningitidis is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.034_b0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.034_b0055","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiological relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0060","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0915162107","article-title":"Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans","volume":"107","author":"Serruto","year":"2010","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.034_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/mBio.00163-13","article-title":"Conservation of meningococcal antigens in the genus Neisseria","volume":"4","author":"Muzzi","year":"2013","journal-title":"MBio"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.034_b0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2958.2004.04423.x","article-title":"Neisseria meningitidis NadA is a new invasin which promotes bacterial adhesion to and penetration into human epithelial cells","volume":"55","author":"Capecchi","year":"2005","journal-title":"Mol Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.034_b0075","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1377\/hlthaff.2011.0295","article-title":"Product development partnerships hit their stride: Lessons from developing a meningitis vaccine for Africa","volume":"30","author":"Bishai","year":"2011","journal-title":"Health Aff"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.034_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0128-6","article-title":"Gonorrhoea","volume":"5","author":"Unemo","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.034_b0085","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1080\/22221751.2019.1681242","article-title":"Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017\u20132018","volume":"8","author":"Yuan","year":"2019","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2023.11.034_b0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.15698\/mic2016.09.524","article-title":"Gonorrhea \u2013 An evolving disease of the new millennium","volume":"3","author":"Hill","year":"2016","journal-title":"Microbial Cell"},{"issue":"2417","key":"10.1016\/j.vaccine.2023.11.034_b0095","first-page":"1","article-title":"Progress Toward a Gonococcal Vaccine: The Way Forward","volume":"10","author":"Russell","year":"2019","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.034_b0100","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1074\/mcp.M116.058800","article-title":"Proteomics-driven antigen discovery for development of vaccines against gonorrhea","volume":"15","author":"Zielke","year":"2016","journal-title":"Mol Cell Proteomics"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.034_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8101521","article-title":"Vaccines against meningococcal diseases","volume":"8","author":"Pizza","year":"2020","journal-title":"Microorganisms"},{"issue":"1053","key":"10.1016\/j.vaccine.2023.11.034_b0110","first-page":"1","article-title":"Outer Membrane Vesicles (OMVs) of Gram-negative bacteria: A perspective update","volume":"8","author":"Jan","year":"2017","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0115","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4161\/hv.7.8.16086","article-title":"Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants","volume":"7","author":"Van Der Ley","year":"2011","journal-title":"Hum Vaccin"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.034_b0120","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid a biosynthesis in Neisseria meningitidis lpxL mutants: Influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"Van Der Ley","year":"2001","journal-title":"Infect Immun"},{"issue":"781280","key":"10.1016\/j.vaccine.2023.11.034_b0125","first-page":"1","article-title":"An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection","volume":"12","author":"van der Ley","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0130","doi-asserted-by":"crossref","first-page":"e0134478","DOI":"10.1371\/journal.pone.0134478","article-title":"Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB","volume":"10","author":"Gerke","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2023.11.034_b0135","doi-asserted-by":"crossref","first-page":"e00699","DOI":"10.1128\/IAI.00699-20","article-title":"Salmonella Paratyphi A Outer Membrane Vesicles Displaying Vi Polysaccharide as a Multivalent Vaccine against Enteric Fever","volume":"89","author":"Gasperini","year":"2021","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.034_b0140","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.034_b0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/hv.23237","article-title":"Neisseria lactamica antigens complexed with a novel cationic adjuvant","volume":"9","author":"Gaspar","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.034_b0150","doi-asserted-by":"crossref","first-page":"e11835","DOI":"10.1371\/journal.pone.0011835","article-title":"Genome sequencing reveals widespread virulence gene exchange among human Neisseria species","volume":"5","author":"Marri","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2023.11.034_b0155","first-page":"1","article-title":"Virulence genes and previously unexplored gene clusters in four commensal Neisseria spp. Isolated from the human throat expand the Neisserial gene repertoire","volume":"6","author":"Calder","year":"2020","journal-title":"Microb Genom"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.034_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines8020219","article-title":"The Neisseria gonorrhoeae vaccine candidate NHBA elicits antibodies that are bactericidal, opsonophagocytic and that reduce gonococcal adherence to epithelial cells","volume":"8","author":"Semchenko","year":"2020","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0165","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3201\/eid2408.180228","article-title":"Fatal non-groupable Neisseria meningitidis disease in vaccinated patient receiving eculizumab","volume":"24","author":"Nolfi-Donegan","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2023.11.034_b0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI116190","article-title":"Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection","volume":"91","author":"Plummer","year":"1993","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.vaccine.2023.11.034_b0175","doi-asserted-by":"crossref","first-page":"e90525","DOI":"10.1371\/journal.pone.0090525","article-title":"Antibodies with higher bactericidal activity induced by a Neisseria gonorrhoeae Rmp deletion mutant strain","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0180","doi-asserted-by":"crossref","first-page":"e1003528","DOI":"10.1371\/journal.ppat.1003528","article-title":"Distinct Binding and Immunogenic Properties of the Gonococcal Homologue of Meningococcal Factor H Binding Protein","volume":"9","author":"Jongerius","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2023.11.034_b0185","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.85.6.1274-1279.1963","article-title":"Neisseria gonorrhoeae. Virulence Genetically Linked to Clonal Variation","volume":"85","author":"Kellogg","year":"1963","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.11.034_b0190","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1753425916684201","article-title":"The Neisseria meningitidis lpxL1 mutant induces less tissue factor expression and activity in primary human monocytes and monocyte-derived microvesicles than the wild type meningococcus","volume":"23","author":"Hellum","year":"2017","journal-title":"Innate Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2023.11.034_b0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from Gram-negative bacteria: Biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2023.11.034_b0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological Functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu Rev Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0205","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1073\/pnas.1218832110","article-title":"Specific DNA recognition mediated by a type IV pilin","volume":"110","author":"Cehovin","year":"2013","journal-title":"PNAS"},{"issue":"6","key":"10.1016\/j.vaccine.2023.11.034_b0210","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2023.11.034_b0215","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1046\/j.1432-1327.2000.01204.x","article-title":"Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion","volume":"267","author":"Schromm","year":"2000","journal-title":"Eur J Biochem"},{"issue":"36","key":"10.1016\/j.vaccine.2023.11.034_b0220","doi-asserted-by":"crossref","first-page":"24922","DOI":"10.1074\/jbc.M114.566570","article-title":"Modulation of endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by genetic lipid A modifications: Relative activation of TLR4 and TLR2 pathways in different mutants","volume":"289","author":"Rossi","year":"2014","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.vaccine.2023.11.034_b0225","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1096\/fj.201902795R","article-title":"Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity","volume":"34","author":"Natali","year":"2020","journal-title":"FASEB J"},{"issue":"48","key":"10.1016\/j.vaccine.2023.11.034_b0230","doi-asserted-by":"crossref","first-page":"41767","DOI":"10.1074\/jbc.M111.289314","article-title":"Structure of the C-terminal domain of Neisseria Heparin Binding Antigen (NHBA), one of the main antigens of a novel vaccine against Neisseria meningitidis","volume":"286","author":"Esposito","year":"2011","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2023.11.034_b0235","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/14760584.2022.2050697","article-title":"Synergistic activity of antibodies in the multicomponent 4CMenB vaccine","volume":"21","author":"Viviani","year":"2022","journal-title":"Expert Rev Vaccin"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23013786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:32:33Z","timestamp":1759404753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23013786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":47,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0264410X23013786"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}